Abstract
Successful weight reduction through lifestyle modification has been shown to improve menstrual regulation and reproductive outcomes in women with PCOS. The optimal diet for an individual with PCOS must not only encompass the short-term goals of weight management and fertility but also must take into account the long-term risk factors associated with this population, such as type 2 diabetes, dyslipidemia, and heart disease. While numerous studies have assessed the relevance of individual macronutrients and diets restricted in one food group or another, long-term data providing conclusive evidence of superiority of one specific type of diet over the other in women with PCOS are lacking. Overall, the balance of existing evidence supports a diet moderate in carbohydrates, high in fiber, and moderate with respect to poly- and monounsaturated fats, with an emphasis on lean sources of protein, as conducive to overall improved health parameters in women with PCOS. Incorporation of regular exercise in daily routines has also demonstrated positive impact on the clinical picture of PCOS. Therefore, management must include lifestyle strategies such as diet and exercise, aimed at optimizing weight and improving insulin sensitivity, to target the spectrum of PCOS-related health concerns.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dunaif A, Segal K, Futterweit W, Dobrjansky A. Profound peripheral insulin resistance; independent of obesity, in polycystic ovarian syndrome. Diabetes. 1989;38:1165–74.
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghn MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovarian syndrome. Diabetes Care. 1999;22:141–74.
Hue L, Taegtmeyer B. The Randle Cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab. 2009;297(3):E578–91.
Legro RD, Kunelman AR, Dodson WC. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovarian syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165–9.
Fultweit W. A patient’s guide to understanding and reversing polycystic ovarian syndrome. New York: Henry Holt and Company; 2006.
Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghn MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovarian syndrome. Diabetes Care. 1999;22:141–74.
Sathyapalan T, Atkin S. Mediators of inflammation in polycystic ovarian syndrome in relation to adiposity. Mediators Inflamm. 2010; 2010:758656.
Marsh K, Steinbeck F, Atkinson P, Petoz J, Brand-Miller J. Effects of low glycemic index compared with a conventional healthy diet on polycystic ovarian syndrome. Am J Clin Nutr. 2010;92:83–92.
Mehrabani H, Salehpour S, Amiri Z, Farahani S, Meyer B, Tahbaz F. Beneficial effects of a high-protein, low-glycemic-load hypocaloric diet in overweight and obese women with polycystic ovarian syndrome: a randomized controlled intervention study. J Am Coll Nutr. 2012;31(2):117–25.
Stamets K. A randomized trials of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril. 2004;142:611–9.
Moran LJ, Noakes M, Clifton M, Tomlisson L, Norman RJ. Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovarian syndrome. J Clin Endocrinol Metabol. 2003;88:812–9.
Wild R. Dislipidemia in PCOS. Steroids. 2012;77:295–9.
Yildirim B, Sabir N, Kaleli B. Relation of intraabdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertil Steril. 2003;79:1358–64.
Potter van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE. The cardiovascular risk factor plasminogen activator inhibitor type 1 is related to insulin resistance. Metabolism. 1993;42(8):945–9.
Lopez-Huerto E. The effect of EPA and DHA on metabolic syndrome patients: a systemic review of randomised controlled trials. Br J Nutr. 2012;107:S185–94.
Duleba AJ, Dokras A. Is PCOS an inflammatory process? Fertil Steril. 2012;97(1):7–12.
Bhathena S. Relationship between fatty acids and the endocrine system. Biofactors. 2000;13:35–9.
Feldsesen S, Tucker K. Nutrition strategies in the treatment of metabolic syndrome. Appl Physiol Nutr Metab. 2007;32:46–60.
Parillo M, Rivellese AA, Ciardullo AV, Capaldo B, Giacco A, Genovese S. A high-monounsaturated-fat/low-carbohydrate diet improves peripheral insulin sensitivity in non-insulin dependent diabetic patients. Metabolism. 1992;41(12):1373–8.
Katan MB, Zock PL. Trans fatty acids and their effects on lipoproteins in humans. Annu Rev Nutr. 1995;15:473–93.
Hu FB, Stampfer MJ, Manson JE, Rimm E, Golditz GA, Rosener B, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997;337:1491–9.
Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arterioscler Thromb. 1992;12:911–9.
Dittas A. The role of vitamin D and calcium in type 2 diabetes. A systemic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017–29.
Shahar D. Does dietary calcium intake enhance weight loss among diabetic patients? Diabetes Care. 2007;30(3):485–9.
Hasson R, Howe C, Jones B, Freedson P. Accuracy of four metabolic rate prediction equations: effects of sex, body mass index, age and race/ethnicity. J Sci Med Sport. 2011;14(4):344–51.
Hawley JA. Exercise as a therapeutic intervention for the prevention and treatment of insulin-resistance. Diabetes Metab Res Rev. 2004;20:383–93.
Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, et al. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92(4):1379–84.
Brown AJ, Setji TL, Sanders LL, Lowry KP, Otvos JD, Kraus WE, Svetkey PL. Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome. Med Sci Sports Exerc. 2009;41(3):497–504.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Krystock, A. (2014). Role of Lifestyle and Diet in the Management of Polycystic Ovarian Syndrome. In: Pal, L. (eds) Polycystic Ovary Syndrome. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8394-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8394-6_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8393-9
Online ISBN: 978-1-4614-8394-6
eBook Packages: MedicineMedicine (R0)